ArticlePharmacoepidemiology and drug safety2020

Rivaroxaban was found to be noninferior to warfarin in routine clinical care: A retrospective noninferiority cohort replication study.

Turki A Althunian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.